Use of Recombinant Activated Factor VII for Bleeding Following Operations Requiring Cardiopulmonary Bypass

This publication has 30 references indexed in Scilit:

• Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation
  The Journal of Thoracic and Cardiovascular Surgery, 2004
• Recombinant activated factor VII for life-threatening pulmonary hemorrhage after pediatric cardiac surgery
  Pediatric Critical Care Medicine, 2003
• Treatment of Excessive Bleeding in Jehovah's Witness Patients after Cardiac Surgery with Recombinant Factor VIIa (NovoSeven®)
  Anesthesiology, 2003
• Successful treatment using recombinant factor VIIa for severe bleeding post cardiopulmonary bypass
  Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 2003
• Hemorrhage After Coronary Artery Bypass Graft Procedures
  Infection Control & Hospital Epidemiology, 2003
• Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant
  Pediatric Critical Care Medicine, 2003
• An Effective Treatment of Severe Intractable Bleeding After Valve Repair by One Single Dose of Activated Recombinant Factor VII
  Anesthesia & Analgesia, 2001
• Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery
  Blood Coagulation & Fibrinolysis, 2000
• Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations
  The Journal of Thoracic and Cardiovascular Surgery, 1996
• Resternotomy for bleeding after cardiac operation: A marker for increased morbidity and mortality
  The Annals of Thoracic Surgery, 1995